RP Bio Inc. (KOSDAQ:314140)

RP Bio Statistics

Total Valuation

RP Bio has a market cap or net worth of KRW 55.46 billion. The enterprise value is 60.29 billion.

Market Cap	55.46B
Enterprise Value	60.29B

Important Dates

Earnings Date	n/a
Ex-Dividend Date	Dec 29, 2025

Share Statistics

RP Bio has 8.67 million shares outstanding. The number of shares has increased by 0.18% in one year.

Current Share Class	8.67M
Shares Outstanding	8.67M
Shares Change (YoY)	+0.18%
Shares Change (QoQ)	+0.23%
Owned by Insiders (%)	61.75%
Owned by Institutions (%)	n/a
Float	3.31M

Valuation Ratios

The trailing PE ratio is 11.83.

PE Ratio	11.83
Forward PE	n/a
PS Ratio	0.41
PB Ratio	0.52
P/TBV Ratio	0.52
P/FCF Ratio	7.62
P/OCF Ratio	4.45
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 5.24, with an EV/FCF ratio of 8.29.

EV / Earnings	12.88
EV / Sales	0.44
EV / EBITDA	5.24
EV / EBIT	11.86
EV / FCF	8.29

Financial Position

The company has a current ratio of 1.30, with a Debt / Equity ratio of 0.18.

Current Ratio	1.30
Quick Ratio	0.75
Debt / Equity	0.18
Debt / EBITDA	1.69
Debt / FCF	2.67
Interest Coverage	6.13

Financial Efficiency

Return on equity (ROE) is 4.47% and return on invested capital (ROIC) is 4.57%.

Return on Equity (ROE)	4.47%
Return on Assets (ROA)	2.01%
Return on Invested Capital (ROIC)	4.57%
Return on Capital Employed (ROCE)	4.55%
Weighted Average Cost of Capital (WACC)	6.42%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.86
Inventory Turnover	5.09

Taxes

Income Tax	-50.91M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +21.67% in the last 52 weeks. The beta is 0.59, so RP Bio's price volatility has been lower than the market average.

Beta (5Y)	0.59
52-Week Price Change	+21.67%
50-Day Moving Average	6,511.60
200-Day Moving Average	6,716.50
Relative Strength Index (RSI)	54.52
Average Volume (20 Days)	12,601

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, RP Bio had revenue of KRW 136.22 billion and earned 4.68 billion in profits. Earnings per share was 541.00.

Revenue	136.22B
Gross Profit	13.81B
Operating Income	5.08B
Pretax Income	4.63B
Net Income	4.68B
EBITDA	11.50B
EBIT	5.08B
Earnings Per Share (EPS)	541.00

Balance Sheet

The company has 14.63 billion in cash and 19.45 billion in debt, with a net cash position of -4.82 billion or -556.32 per share.

Cash & Cash Equivalents	14.63B
Total Debt	19.45B
Net Cash	-4.82B
Net Cash Per Share	-556.32
Equity (Book Value)	107.20B
Book Value Per Share	12,364.48
Working Capital	13.18B

Cash Flow

In the last 12 months, operating cash flow was 12.48 billion and capital expenditures -5.20 billion, giving a free cash flow of 7.28 billion.

Operating Cash Flow	12.48B
Capital Expenditures	-5.20B
Depreciation & Amortization	6.41B
Net Borrowing	-9.69B
Free Cash Flow	7.28B
FCF Per Share	839.54

Margins

Gross margin is 10.14%, with operating and profit margins of 3.73% and 3.44%.

Gross Margin	10.14%
Operating Margin	3.73%
Pretax Margin	3.40%
Profit Margin	3.44%
EBITDA Margin	8.44%
EBIT Margin	3.73%
FCF Margin	5.34%

Dividends & Yields

This stock pays an annual dividend of 50.00, which amounts to a dividend yield of 0.78%.

Dividend Per Share	50.00
Dividend Yield	0.78%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.18%
Shareholder Yield	0.60%
Earnings Yield	8.44%
FCF Yield	13.12%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

RP Bio has an Altman Z-Score of 2.07 and a Piotroski F-Score of 7. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.07
Piotroski F-Score	7